Cite
HARVARD Citation
Wei, G. et al. (n.d.). Entrectinib, a highly potent pan-Trk, ROS1, and ALK inhibitor, has broad-spectrum, histology-agnostic anti-tumor activity in molecularly defined cancers. European journal of cancer. pp. S33-. [Online].